The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation

Raloxifene is a selective estrogen receptor modulator typically prescribed for the prevention/treatment of osteoporosis in postmenopausal women. Although raloxifene is known to have anti-inflammatory properties, its effects on human neutrophils, the primary phagocytic leukocytes of the immune system...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores, Roxana, Döhrmann, Simon, Schaal, Christina, Hakkim, Abdul, Nizet, Victor, Corriden, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141331/
https://www.ncbi.nlm.nih.gov/pubmed/28003814
http://dx.doi.org/10.3389/fimmu.2016.00566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141331/
https://www.ncbi.nlm.nih.gov/pubmed/28003814
http://dx.doi.org/10.3389/fimmu.2016.00566

Ejemplares similares